BEYFORTUS™ Nirsevimab-alip 50 mg / 0.5 mL Injection 0.5 mL

Name: Respiratory Syncytial Virus Vaccine
Brand: BEYFORTUS™

BEYFORTUS, PFS 50MG/0.5ML (5/BX)

McKesson #

1235487

Manufacturer #

49281057515

Brand

BEYFORTUS™

Manufacturer

Sanofi Pasteur

Country of Origin

United States

Application

Respiratory Syncytial Virus Vaccine

Container Type

Prefilled Syringe

Dosage Form

Injection

Generic Drug Code

54466

Generic Drug Name

Nirsevimab-alip

NDC Number

49281057515

Product Dating

McKesson Acceptable Dating: we will ship >= 180 days

Storage Requirements

Requires Refrigeration

Strength

50 mg / 0.5 mL

Type

Intramuscular

UNSPSC Code

51201600

User

Indicated for People from Birth Through 24 Months of Age

Volume

0.5 mL

BEYFORTUS is a respiratory syncytial virus (RSV) F protein‑directed fusion inhibitor indicated for the prevention of RSV lower respiratory tract disease
BEYFORTUS is an antibody that contains nirsevimab-alip which is used to help prevent RSV disease for 5 months
Indicated for Newborns and babies under 1 year of age born during or entering their first RSV season, and children up to 24 months of age who remain at risk of severe RSV disease through their second RSV season
For Intramuscular Injection Only